Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Corticotropin-releasing hormone is secreted by the paraventricular nucleus (PVN) of the hypothalamus in response to stress. Additionally we are shipping CRH Kits (89) and CRH Proteins (25) and many more products for this protein.
Showing 10 out of 173 products:
Mouse (Murine) Polyclonal CRH Primary Antibody for IEM, ICC - ABIN617894
Preeyasombat, Sirikulchayanonta, Mahachokelertwattana, Sriphrapradang, Boonpucknavig: Cushing's syndrome caused by Ewing's sarcoma secreting corticotropin releasing factor-like peptide. in American journal of diseases of children (1960) 1992
Show all 22 references for ABIN617894
Mouse (Murine) Polyclonal CRH Primary Antibody for WB - ABIN610920
Cowin: Unraveling the cytoplasmic interactions of the cadherin superfamily. in Proceedings of the National Academy of Sciences of the United States of America 1994
Show all 4 references for ABIN610920
Human Monoclonal CRH Primary Antibody for ELISA, WB - ABIN514593
Wang, Parobchak, Rosen: RelB/NF-?B2 regulates corticotropin-releasing hormone in the human placenta. in Molecular endocrinology (Baltimore, Md.) 2012
Show all 3 references for ABIN514593
Human Polyclonal CRH Primary Antibody for EIA, WB - ABIN951671
Ruaño, Thompson, Kane, Pullinger, Windemuth, Seip, Kocherla, Holford, Wu: Physiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol? in Pharmacogenomics 2010
Show all 2 references for ABIN951671
Human Monoclonal CRH Primary Antibody for EIA, IHC (p) - ABIN111808
Kravchenko, Furalev: Monoclonal antibodies directed against two different corticotropin-releasing factor determinants. in Hybridoma 1994
Rigorous acute stressor stimuli induce behavioral changes, accompanied by an increase of cortisol levels with delayed control of CRH mRNA expression.
CRF localized in the preoptic area, periventricular hypothalamic and tectal regions, and dorsal part of the trigeminal motor nucleus.
The association has been reported between polymorphisms of the CRH and POMC (show POMC Antibodies) genes with economic traits in Korean cattle.
CRH is a promising candidate gene for a concordant QTL related to lipid metabolism in mammals.
We show that -2232C>G alters DNA x protein interactions and confers decreased sensitivity of the CRH promoter to glucocorticoids in vitro.
Data suggest that CRH promoter variation that confers increased stress reactivity increases the risk for alcohol use disorders in stress-exposed individuals.
corticotropin-releasing factor mRNA fluctuated with food intake in the hypothalamus, pretectum, and optic tectum; CRF mRNA decreased 6 h after a meal and remained low through 31 days of food deprivation
Data suggest a physiologically relevant role for local corticotropin-releasing hormone signaling towards shaping the neuronal circuitry within the mouse olfactory bulb.
results suggest that long-term, post-natal CRF over-expression increases the rewarding effects of cocaine in individuals with high emotional response to stress.
Knockdown of CRF synthesis in the ventral tegmental area prevented interpeduncular intermediate activation and anxiety during nicotine withdrawal.
selective disruption of Grin1 (show GRIN1 Antibodies) within central amygdala CRF neurons strongly enhances fear memory
it is shown that CRH and UCN (show UCN Antibodies) upregulate galectin-1 (show LGALS1 Antibodies) expression in Ishikawa cell line and macrophages and this effect is mediated through CRHR1 (show CRHR1 Antibodies).
CRF overexpression throughout the CNS increased startle magnitude and reduced ability to inhibit startle. CRF overexpression confined to inhibitory neurons decreased startle magnitude but had no effect on inhibitory measures.
The stress response neuropeptide CRF increases amyloid-beta production by regulating gamma-secretase activity.
These data suggest critical roles for CRF and CRFR1 (show CRHR1 Antibodies) in tau-P and aggregation and may have implications for the development of Alzheimer disease cognitive decline.
Study of sex- and genotype-dependent effects of a short, acute predator odor exposure on CRF mRNA levels in stress-related brain regions and subsequently changes in spatial memory retrieval in male and female GAD67 (show GAD1 Antibodies) mice and their wildtype littermates
Signal transduction via C1qL1 (show C1ql1 Antibodies)-BAI3 (show BAI3 Antibodies) interaction is required for motor learning, triggers pruting of surplus cerebellar climbing fibers, and is required to maintain climbing fiber synapses.
Placenta CRH mRNA concentration appears to convey information about the risk of brain damage in the infant born at an extremely low gestational age.
These results suggest that the CRH and CRH-BP (show CRHBP Antibodies) genes have no direct effect on Irritable bowel syndrome status.
This study evaluated the associations of CRH polymorphisms with susceptibility to MDD and response to antidepressant treatment
results suggest that glucocorticoids induce a transcription complex consisting of RelB (show RELB Antibodies)/p52 (show FKBP4 Antibodies), CBP (show CREBBP Antibodies), and HDAC1 (show HDAC1 Antibodies) that triggers a dynamic acetylation-mediated epigenetic change to induce CRH expression in full-term human placenta.
Interaction of RelB (show RELB Antibodies) with the CRH or COX-2 (show COX2 Antibodies) gene promoters decreased when STAT3 (show STAT3 Antibodies) was depleted.
the present study demonstrates that the expression of CRH/CRH-R1 (show CRHR1 Antibodies) in lesions of chronic plaque psoriasis is lower than that in psoriatic perilesional skin and normal control skin.
results show that activation of CRH receptors by CRH ligands stimulates VEGF-A (show VEGFA Antibodies) expression in intestinal epithelial cells through the cAMP/CREB (show CREB1 Antibodies) pathway
This corticotropin releasing factor-induced regulation on norepinephrine transporter (show SLC6A2 Antibodies) expression and function may play a role in development of stress-related depression and anxiety
Placental CRH exposure may make a unique contribution to fetal programming of obesity risk.
Data suggest that signal transduction involving corticotropin-releasing factor (CRH) and CRH receptors (CRHR (show CRHR1 Antibodies)) taking place in cochlea are involved in protecting against noise-induced hearing loss. [REVIEW]
Evidence is provided for porcine corticotropin releasing hormone (CRH) as a quantitative trait locus (QTL) affecting growth and body composition. (corticotropin releasing hormone; CRH; CRF)
CRH inhibits local progesterone production from luteal cells in swine corpus lutem.
Corticotropin-releasing hormone is secreted by the paraventricular nucleus (PVN) of the hypothalamus in response to stress. Marked reduction in this protein has been observed in association with Alzheimer disease and autosomal recessive hypothalamic corticotropin deficiency has multiple and potentially fatal metabolic consequences including hypoglycemia and hepatitis. In addition to production in the hypothalamus, this protein is also synthesized in peripheral tissues, such as T lymphocytes and is highly expressed in the placenta. In the placenta it is a marker that determines the length of gestation and the timing of parturition and delivery. A rapid increase in circulating levels of the hormone occurs at the onset of parturition, suggesting that, in addition to its metabolic functions, this protein may act as a trigger for parturition.
, corticotropin releasing hormone
, corticotropin releasing hormone-like
, corticotropin releasing hormone, gene 1
, corticotropin-releasing factor b
, corticotropin releasing hormone b
, C1q and tumor necrosis factor-related protein 14
, C1q related factor
, C1q-related factor
, C1q/TNF-related protein 14
, corticotropin-releasing factor
, corticotropin-releasing hormone
, corticotropin releasing factor
, corticotrophin-releasing factor
, Corticotropin-releasing hormone
, corticotropin releasing hormone a
, corticotropin-releasing factor a